Literature DB >> 26542739

An overview of pregnancy and fertility issues in breast cancer patients.

Charlotta Dabrosin1.   

Abstract

Breast cancer is one of the most common malignancies of women in the reproductive years. In the Western world there is a trend towards delaying pregnancy to later in life, and in combination with an increased incidence of breast cancer an increased number of women are diagnosed with breast cancer before they have completed their reproductive plans. In addition, breast cancer during pregnancy may affect an increased number of women as the childbearing years are delayed. The survival rate after breast cancer has improved during the last decades, and many young breast cancer survivors will consider a pregnancy subsequent to the completion of adjuvant breast cancer therapy. Traditionally, many women are advised against a pregnancy due to a fear of increased risk of recurrence, especially women with estrogen receptor-positive breast cancer. Due to feasibility issues, evidence from large prospective randomized trials is missing regarding the safety of pregnancy after breast cancer. Today guidelines are based on cohort studies and population-based registry evidence with its limitations. Overall, data suggest that pregnancy after breast cancer therapy is safe, and the current evidence is summarized in this overview.

Entities:  

Keywords:  Breast cancer; estrogen receptor; fertility; mammary cancer; pregnancy

Mesh:

Year:  2015        PMID: 26542739     DOI: 10.3109/07853890.2015.1096953

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  2 in total

1.  Impact of tamoxifen therapy on fertility in breast cancer survivors.

Authors:  Lisa M Shandley; Jessica B Spencer; Amy Fothergill; Ann C Mertens; Amita Manatunga; Elisavet Paplomata; Penelope P Howards
Journal:  Fertil Steril       Date:  2016-11-22       Impact factor: 7.329

2.  Conception after chemotherapy: post-chemotherapy method of conception and pregnancy outcomes in breast cancer patients.

Authors:  Mary Kathryn Abel; Kaitlyn Wald; Nikita Sinha; Joseph M Letourneau; Rhodel Simbulan; Evelyn Mok-Lin; Marcelle I Cedars; Mitchell P Rosen
Journal:  J Assist Reprod Genet       Date:  2021-03-19       Impact factor: 3.357

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.